##semicolon##
болезнь Паркинсона, витамин D, остеопения, остеопороз, минеральная плот-ность, костная ткань, 25(OH)D, нейродегенерация, абсорбциометрия, корреляция.##submission.citations##
Kalia, L. V., & Lang, A. E. (2015). Parkinson’s disease. The Lancet, 386(9996), 896-912. https://doi.org/10.1016/S0140-6736(14)61393-3
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. (2014). The prevalence of Parkinson’s disease: A systematic review and meta-analysis. Mo-vement Disorders, 29(13), 1583-1590. https://doi. org/10.1002/mds.25945
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J.,... & Lang, A. E. (2017). Parkinson disease. Nature Reviews Disease Primers, 3, 17013. https://doi.org/10.1038/nrdp.20 17.13
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017). Non-motor features of Parkinson disease. Nature Reviews Neuroscience, 18(7), 435-450. https://doi.org/10.1038/nrn.2017.62
Sulzer, D., et al. (2017). Neurodegeneration in Parkinson disease: From pathways to therapeutics. Science, 358(6361), 1-13. https://doi.org/1 0.1126/science.aan7611
Chaudhuri, K. R., & Schapira, A. H. V. (2009). Non-motor symptoms of Parkinson’s disease: Dopaminergic pathophysiology and treatment. The Lancet Neurology, 8(5), 464-474. https://doi. org/10.1016/S1474-4422(09)70068-7
Holick, M. F. (2007). Vitamin D deficiency. The New England Journal of Medicine, 357(3), 266-281. https://doi.org/10.1056/NEJMra070553
Eyles, D. W., Smith, S., Kinobe, R., Hewison, M., & McGrath, J. J. (2005). Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. Journal of Chemical Neuroanatomy, 29(1), 21-30. https://doi.org/10.1016/j.jchemneu.2004.08.006
Evatt, M. L., DeLong, M. R., Kumari, M., Auinger, P., McDermott, M. P., & Factor, S. A. (2011). Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Archives of Neurology, 68(3), 314-319. https://doi.org/10.1001 /archneurol.2010.346
Peterson, A. L., & Bostrom, A. (2019). Bone health in Parkinson’s disease: A review. Movement Disorders Clinical Practice, 6(4), 277-284. https:// doi.org/10.1002/mdc3.12752
Grigoriadis, N., & Benvenga, S. (2015). Vitamin D deficiency and Parkinson’s disease: A possible risk factor? Endocrine, 49(3), 553-556. https:// doi.org/10.1007/s12020-014-0435-x
Wang, L., Tan, L., Tan, L., & Yu, J. T. (2014). Vitamin D and Parkinson’s disease: A meta-analysis. Neurological Sciences, 35(10), 1507-1512. https:// doi.org/10.1007/s10072-014-1772-x
Kocovska, E., Gaughran, F., & Krivoy, A. (2017). Vitamin D and bone health in patients with schizophrenia and Parkinson’s disease: A narrative review. Journal of Clinical Medicine, 6(8), 77. https:// doi.org/10.3390/jcm6080077
Buell, J. S., & Dawson-Hughes, B. (2008). Vitamin D and neurocognitive dysfunction: Preventing “D”ecline? Molecular Aspects of Medicine, 29(6), 415-422. https://doi.org/10.1016/j.mam.2008.08.0
Peterson, A. L., & Bostrom, A. (2018). Bone loss in Parkinson’s disease. Neurodegenerative Disease Management, 8(6), 447-456. https://doi.org/ 10.2217/nmt-2018-0017
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2007). Fracture risk in patients with Parkinson’s disease, epilepsy, and stroke: A nationwide follow-up study. Osteoporosis International, 18(2), 133-138. https://doi.org/10.1007/s00198-006-0224-3